Angiogenesis-dependent diseases

被引：184
作者：
Folkman, J
机构：
[1] Harvard Univ, Sch Med, Childrens Hosp, Dept Surg, Boston, MA 02115 USA
[2] Childrens Hosp, Surg Res Lab, Dept Surg, Boston, MA 02115 USA
来源：
SEMINARS IN ONCOLOGY | 2001年 / 28卷 / 06期
关键词：
D O I：
10.1053/sonc.2001.29543
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：536 / 542
页数：7
相关论文
共 42 条
  • [1] Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia
    Aguayo, A
    Estey, E
    Kantarjian, H
    Mansouri, T
    Gidel, C
    Keating, M
    Giles, F
    Estrov, Z
    Barlogie, B
    Albitar, M
    [J]. BLOOD, 1999, 94 (11) : 3717 - 3721
  • [2] Thalidomide in multiple myeloma, myelodysplastic syndromes and histiocytosis. Analysis of clinical results and of surrogate angiogenesis markers
    Bertolini, F
    Mingrone, W
    Alietti, A
    Ferrucci, PF
    Cocorocchio, E
    Peccatori, F
    Cineri, S
    Mancuso, P
    Corsini, C
    Burlini, A
    Zucca, E
    Martinelli, G
    [J]. ANNALS OF ONCOLOGY, 2001, 12 (07) : 987 - 990
  • [3] Browder T, 2000, CANCER RES, V60, P1878
  • [4] BRUNNER G, 1993, BLOOD, V81, P631
  • [5] THALIDOMIDE IS AN INHIBITOR OF ANGIOGENESIS
    DAMATO, RJ
    LOUGHNAN, MS
    FLYNN, E
    FOLKMAN, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) : 4082 - 4085
  • [6] Folkman J, 2001, THROMB HAEMOSTASIS, V86, P23
  • [7] FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182
  • [8] FOLKMAN J, 2000, CANC MED, P132
  • [9] Folkman J., 1997, CLIN APPL INTERFERON, P255
  • [10] Folkman J., 2001, HARRISONS PRINCIPLES, V15th ed., P517
12345